Global Controlled-Release Drug Delivery Technology 麻豆原创 Research Report 2023

Publication ID:

PB502231940

Publication Date:

February 1, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Controlled-Release Drug Delivery Technology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Controlled-Release Drug Delivery Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Controlled-Release Drug Delivery Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Controlled-Release Drug Delivery Technology in Metered Dose Inhalers is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Controlled-Release Drug Delivery Technology include Depomed, Coating Place, Corium International, Johnson and Johnson, Alkermes, Pfizer, Orbis Biosciences, Capsugel and Merck and Co, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Controlled-Release Drug Delivery Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Controlled-Release Drug Delivery Technology.
The Controlled-Release Drug Delivery Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Controlled-Release Drug Delivery Technology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Controlled-Release Drug Delivery Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Depomed
Coating Place
Corium International
Johnson and Johnson
Alkermes
Pfizer
Orbis Biosciences
Capsugel
Merck and Co
Aradigm
Segment by Type
Wurster Technique
Coacervation
Micro Encapsulation
Implants
Transdermal
Targeted Delivery
Others
Segment by Application
Metered Dose Inhalers
Injectables
Transdermal and Ocular Patches
Infusion Pumps
Oral Controlled-Drug Delivery Systems
Drug Eluting Stents
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Controlled-Release Drug Delivery Technology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Controlled-Release Drug Delivery Technology 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Wurster Technique
1.2.3 Coacervation
1.2.4 Micro Encapsulation
1.2.5 Implants
1.2.6 Transdermal
1.2.7 Targeted Delivery
1.2.8 Others
1.3 麻豆原创 by Application
1.3.1 Global Controlled-Release Drug Delivery Technology 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Metered Dose Inhalers
1.3.3 Injectables
1.3.4 Transdermal and Ocular Patches
1.3.5 Infusion Pumps
1.3.6 Oral Controlled-Drug Delivery Systems
1.3.7 Drug Eluting Stents
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Controlled-Release Drug Delivery Technology 麻豆原创 Perspective (2018-2029)
2.2 Controlled-Release Drug Delivery Technology Growth Trends by Region
2.2.1 Global Controlled-Release Drug Delivery Technology 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Controlled-Release Drug Delivery Technology Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Controlled-Release Drug Delivery Technology Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Controlled-Release Drug Delivery Technology 麻豆原创 Dynamics
2.3.1 Controlled-Release Drug Delivery Technology Industry Trends
2.3.2 Controlled-Release Drug Delivery Technology 麻豆原创 Drivers
2.3.3 Controlled-Release Drug Delivery Technology 麻豆原创 Challenges
2.3.4 Controlled-Release Drug Delivery Technology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Controlled-Release Drug Delivery Technology Players by Revenue
3.1.1 Global Top Controlled-Release Drug Delivery Technology Players by Revenue (2018-2023)
3.1.2 Global Controlled-Release Drug Delivery Technology Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Controlled-Release Drug Delivery Technology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Controlled-Release Drug Delivery Technology Revenue
3.4 Global Controlled-Release Drug Delivery Technology 麻豆原创 Concentration Ratio
3.4.1 Global Controlled-Release Drug Delivery Technology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Controlled-Release Drug Delivery Technology Revenue in 2022
3.5 Controlled-Release Drug Delivery Technology Key Players Head office and Area Served
3.6 Key Players Controlled-Release Drug Delivery Technology Product Solution and Service
3.7 Date of Enter into Controlled-Release Drug Delivery Technology 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Controlled-Release Drug Delivery Technology Breakdown Data by Type
4.1 Global Controlled-Release Drug Delivery Technology Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Controlled-Release Drug Delivery Technology Forecasted 麻豆原创 Size by Type (2024-2029)
5 Controlled-Release Drug Delivery Technology Breakdown Data by Application
5.1 Global Controlled-Release Drug Delivery Technology Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Controlled-Release Drug Delivery Technology Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Controlled-Release Drug Delivery Technology 麻豆原创 Size (2018-2029)
6.2 North America Controlled-Release Drug Delivery Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Controlled-Release Drug Delivery Technology 麻豆原创 Size by Country (2018-2023)
6.4 North America Controlled-Release Drug Delivery Technology 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Controlled-Release Drug Delivery Technology 麻豆原创 Size (2018-2029)
7.2 Europe Controlled-Release Drug Delivery Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Controlled-Release Drug Delivery Technology 麻豆原创 Size by Country (2018-2023)
7.4 Europe Controlled-Release Drug Delivery Technology 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Controlled-Release Drug Delivery Technology 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Controlled-Release Drug Delivery Technology 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Controlled-Release Drug Delivery Technology 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Controlled-Release Drug Delivery Technology 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Controlled-Release Drug Delivery Technology 麻豆原创 Size (2018-2029)
9.2 Latin America Controlled-Release Drug Delivery Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Controlled-Release Drug Delivery Technology 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Controlled-Release Drug Delivery Technology 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Controlled-Release Drug Delivery Technology 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Controlled-Release Drug Delivery Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Controlled-Release Drug Delivery Technology 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Controlled-Release Drug Delivery Technology 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Depomed
11.1.1 Depomed Company Detail
11.1.2 Depomed Business Overview
11.1.3 Depomed Controlled-Release Drug Delivery Technology Introduction
11.1.4 Depomed Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.1.5 Depomed Recent Development
11.2 Coating Place
11.2.1 Coating Place Company Detail
11.2.2 Coating Place Business Overview
11.2.3 Coating Place Controlled-Release Drug Delivery Technology Introduction
11.2.4 Coating Place Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.2.5 Coating Place Recent Development
11.3 Corium International
11.3.1 Corium International Company Detail
11.3.2 Corium International Business Overview
11.3.3 Corium International Controlled-Release Drug Delivery Technology Introduction
11.3.4 Corium International Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.3.5 Corium International Recent Development
11.4 Johnson and Johnson
11.4.1 Johnson and Johnson Company Detail
11.4.2 Johnson and Johnson Business Overview
11.4.3 Johnson and Johnson Controlled-Release Drug Delivery Technology Introduction
11.4.4 Johnson and Johnson Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.4.5 Johnson and Johnson Recent Development
11.5 Alkermes
11.5.1 Alkermes Company Detail
11.5.2 Alkermes Business Overview
11.5.3 Alkermes Controlled-Release Drug Delivery Technology Introduction
11.5.4 Alkermes Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.5.5 Alkermes Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Controlled-Release Drug Delivery Technology Introduction
11.6.4 Pfizer Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.6.5 Pfizer Recent Development
11.7 Orbis Biosciences
11.7.1 Orbis Biosciences Company Detail
11.7.2 Orbis Biosciences Business Overview
11.7.3 Orbis Biosciences Controlled-Release Drug Delivery Technology Introduction
11.7.4 Orbis Biosciences Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.7.5 Orbis Biosciences Recent Development
11.8 Capsugel
11.8.1 Capsugel Company Detail
11.8.2 Capsugel Business Overview
11.8.3 Capsugel Controlled-Release Drug Delivery Technology Introduction
11.8.4 Capsugel Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.8.5 Capsugel Recent Development
11.9 Merck and Co
11.9.1 Merck and Co Company Detail
11.9.2 Merck and Co Business Overview
11.9.3 Merck and Co Controlled-Release Drug Delivery Technology Introduction
11.9.4 Merck and Co Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.9.5 Merck and Co Recent Development
11.10 Aradigm
11.10.1 Aradigm Company Detail
11.10.2 Aradigm Business Overview
11.10.3 Aradigm Controlled-Release Drug Delivery Technology Introduction
11.10.4 Aradigm Revenue in Controlled-Release Drug Delivery Technology Business (2018-2023)
11.10.5 Aradigm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Depomed
Coating Place
Corium International
Johnson and Johnson
Alkermes
Pfizer
Orbis Biosciences
Capsugel
Merck and Co
Aradigm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.